![Takashi Shimada](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: 181 487 $ al 31/05/2026
Takashi Shimada is currently Chairman at KMT Hepatech, Inc. since 2017, Chairman at PhoenixBio USA Corp.
since 2018, and President & Representative Director at PhoenixBio Co., Ltd. since 2018.
Formerly, Mr. Shimada was Director & Administration Manager at Institute of Immunology Co., Ltd.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
PHOENIXBIO CO., LTD. 1,68 % | 30/09/2025 | 68.300 ( 1,68 % ) | 181 487 $ | 31/05/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| PHOENIXBIO CO., LTD. | Presidente | 28/06/2018 |
PhoenixBio USA Corp.
 PhoenixBio USA Corp. Miscellaneous Commercial ServicesCommercial Services Develops technologies for mass propagation of human cells into laboratory animals | Presidente | 01/06/2018 |
KMT Hepatech, Inc.
 KMT Hepatech, Inc. Miscellaneous Commercial ServicesCommercial Services Develops methods to support human liver cells in a mouse that allows support of infections | Presidente | 01/12/2017 |
| Empresas | Cargo | Fin |
|---|---|---|
Institute of Immunology Co., Ltd.
 Institute of Immunology Co., Ltd. Medical SpecialtiesHealth Technology Develops and produces diagnostic reagents and monoclonal antibodies | Director Administrativo | - |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 4 |
|---|---|
KMT Hepatech, Inc.
KMT Hepatech, Inc. Miscellaneous Commercial ServicesCommercial Services Develops methods to support human liver cells in a mouse that allows support of infections | Commercial Services |
Institute of Immunology Co., Ltd.
Institute of Immunology Co., Ltd. Medical SpecialtiesHealth Technology Develops and produces diagnostic reagents and monoclonal antibodies | Health Technology |
PhoenixBio Co., Ltd.
 PhoenixBio Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Develops technologies for mass propagation of human cells into laboratory animals | Commercial Services |
PhoenixBio USA Corp.
PhoenixBio USA Corp. Miscellaneous Commercial ServicesCommercial Services Develops technologies for mass propagation of human cells into laboratory animals | Commercial Services |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
